David Craig
President and CEO,
Sarcomatrix Therapeutics Corp
United States
David Craig is the dynamic CEO of Sarcomatrix Therapeutics Corp, a company at the forefront of muscle health innovation. With decades of experience in biotechnology and a proven track record of translating cutting-edge science into breakthrough therapies, David leads Sarcomatrix’s efforts to revolutionize muscle care through novel small molecule and protein programs.
Before joining Sarcomatrix, David held executive roles at leading biopharmaceutical companies, where he successfully steered advanced therapeutic programs from early-stage development through commercialization. His expertise in strategic planning, clinical development, and fostering strategic partnerships has consistently driven transformative advancements in regenerative medicine and targeted therapeutics.
A recognized thought leader and frequent speaker at industry events, David is passionate about bridging the gap between scientific discovery and patient care. At the BIO CEO Investor Conference, he will share insights on leveraging innovative matrix-based platforms to enhance muscle regeneration and performance, underscoring his commitment to improving quality of life through next-generation therapies.
Suffix
MBA
Sessions
-
10-Feb-2025Sarcomatrix Therapeutics Corp.
)
){kind=logo}
)
){kind=logo}
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}
){kind=logo}